Hadean Ventures
Hadean Ventures is a life science investment firm based in Oslo, Norway, focused on the healthcare sector across Europe, particularly in the Nordic region. Founded in 2014, the firm manages a venture capital fund, Hadean Capital II, which was launched in 2021. Hadean Ventures invests in a variety of life science companies, including those in pharmaceuticals, biotechnology, and digital health. The firm is supported by a network of prominent private and institutional investors and has established collaborations with leading academic institutions and startup hubs throughout the region. With offices in Oslo and Stockholm, Hadean Ventures aims to foster innovation and growth in the life sciences sector.
Oncoinvent AS develops antibody based therapeutics for cancer patients. It offers Radspherin, an alpha-emitting radioactive microsphere designed for treatment of metastatic cancers in body cavities; radiotherapeuti; radioimmunotherapeutic; and immunotherapeutic products. The company was founded in 2010 and is based in Oslo, Norway.
Oncoinvent AS develops antibody based therapeutics for cancer patients. It offers Radspherin, an alpha-emitting radioactive microsphere designed for treatment of metastatic cancers in body cavities; radiotherapeuti; radioimmunotherapeutic; and immunotherapeutic products. The company was founded in 2010 and is based in Oslo, Norway.